US Stock MarketDetailed Quotes
ARTH ARCH THERAPEUTICS INC
- 1.050000
- -0.130000-11.02%
15min DelayTrading Apr 19 12:30 ET
4.98MMarket Cap-750P/E (TTM)
1.215000High1.050000Low10.73KVolume1.195000Open1.180000Pre Close12.94KTurnover0.23%Turnover RatioLossP/E (Static)4.74MShares18.00000052wk High-0.52P/B4.88MFloat Cap0.39000052wk Low--Dividend TTM4.65MShs Float28.000000Historical High--Div YieldTTM13.98%Amplitude0.390000Historical Low1.205000Avg Price1Lot Size
About ARCH THERAPEUTICS INC Company
Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.
Company Profile
SymbolARTH
Company NameARCH THERAPEUTICS INC
Founded2009
MarketPink Market
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address235 Walnut Street,Suite 6
CityFramingham
ProvinceMassachusetts
CountryUnited States of America
Zip Code01702
Phone1-617-431-2313
Company Executives
- Name
- Position
- Salary
- Dr. Terrence W. Norchi
- Chairman of the Board, President and Chief Executive Officer
- --
- Richard E. Davis
- Chief Financial Officer and Chief Accounting Officer
- --
- James R. Sulat
- Independent Director
- --
- Punit Dhillon
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg